Literature DB >> 2784378

Tissue-specific regulation of human alpha 1-antitrypsin gene expression in transgenic mice.

R F Shen1, S M Clift, J L DeMayo, R N Sifers, M J Finegold, S L Woo.   

Abstract

The 5'-flanking sequence of the human alpha 1-antitrypsin (AAT) gene contains multiple cis-regulatory elements, including a distal enhancer and proximal sequences essential for its transcription in cultured hepatoma cells. To understand better the promoter specificity of the AAT gene in vivo, transgenic mice harboring the AAT-SV40 hybrid promoter or the natural AAT promoter fused to a reporter gene (CAT) were generated. Examination of CAT activity in various tissues indicated that the CAT gene was expressed primarily in the liver and also, to a lesser extent, in tissues known to express the AAT gene. In addition, the cis-acting elements of the human AAT gene were utilized to drive the transcription of the SV40 T antigen gene in transgenic mice. Hepatocellular malignancy was found in all founder animals examined, while sporadic occurrence of malignancy was also observed in stomach, pancreas, and kidney. These results verify that the 5'-flanking region of the human AAT gene contains cis-regulatory elements sufficient to confer tissue specificity in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784378     DOI: 10.1089/dna.1.1989.8.101

Source DB:  PubMed          Journal:  DNA        ISSN: 0198-0238


  8 in total

1.  Chromosomal elements regulate gene activity and chromatin structure of the human serpin gene cluster at 14q32.1.

Authors:  Mark D Marsden; R E K Fournier
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

2.  TWEAK induces liver progenitor cell proliferation.

Authors:  Aniela Jakubowski; Christine Ambrose; Michael Parr; John M Lincecum; Monica Z Wang; Timothy S Zheng; Beth Browning; Jennifer S Michaelson; Manfred Baetscher; Manfred Baestcher; Bruce Wang; D Montgomery Bissell; Linda C Burkly
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

3.  Identification of a key regulatory element for the basal activity of the human insulin-like growth factor II gene promoter P3.

Authors:  L E Rietveld; P E Holthuizen; J S Sussenbach
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

4.  Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice.

Authors:  T H Lee; M J Finegold; R F Shen; J L DeMayo; S L Woo; J S Butel
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.

Authors:  C Fraefel; D R Jacoby; C Lage; H Hilderbrand; J Y Chou; F W Alt; X O Breakefield; J A Majzoub
Journal:  Mol Med       Date:  1997-12       Impact factor: 6.354

6.  Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation.

Authors:  K P Ponder; S Gupta; F Leland; G Darlington; M Finegold; J DeMayo; F D Ledley; J R Chowdhury; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

7.  Restricted tissue-specific but correct developmental expression mediated by a short human alpha 1AT promoter fragment in transgenic mice.

Authors:  F E Yull; R M Wallace; A J Clark
Journal:  Transgenic Res       Date:  1995-01       Impact factor: 2.788

8.  High blood pressure in transgenic mice carrying the rat angiotensinogen gene.

Authors:  S Kimura; J J Mullins; B Bunnemann; R Metzger; U Hilgenfeldt; F Zimmermann; H Jacob; K Fuxe; D Ganten; M Kaling
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.